JPS5775991A - Novel physiologically active substance jcv-80 - Google Patents
Novel physiologically active substance jcv-80Info
- Publication number
- JPS5775991A JPS5775991A JP55151235A JP15123580A JPS5775991A JP S5775991 A JPS5775991 A JP S5775991A JP 55151235 A JP55151235 A JP 55151235A JP 15123580 A JP15123580 A JP 15123580A JP S5775991 A JPS5775991 A JP S5775991A
- Authority
- JP
- Japan
- Prior art keywords
- agent
- jcv
- virus
- tissue
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
NEW MATERIAL:The physiologically active substance JCV-80 having the following characteristics: appearance, white, amorphous hygroscopic powder; solubility, soluble in water, methanol, and ethanol; UV-absorption spectrum, λmax=255W275nm; color reactions, positive to Molish reaction, etc., and negative to protein detection reaction.
USE: Biophlaxis-regulating agent such as immunoregulating agent, antitumor agent, antistress agent, autonomic nerve regulating agent, antiallergic agent, etc.
PROCESS: Tumor cell is transplanted to a warm-blooded animal (e.g., poultry such as chicken, dove, etc., mammalian such as cattle, horse, etc.) or to the cultured tissue originated from warm-blooded animal, and at the same time, the animal or the tissue is inoculated with pox virus (e.g. vaccinia virus, cowpox virus, ectromelia virus, etc.) to cause the variola. The resulted inflammatory tissue or cultured tissue is ground and subjected to the protein-removal process to obtain the biophlaxis- regulating substance JCV-80. The removal of the proteins can be carried out, e.g. by heating, irradiation with ultrasonic radiation, treatment with protein-denaturating agent, etc.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55151235A JPS5775991A (en) | 1980-10-27 | 1980-10-27 | Novel physiologically active substance jcv-80 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55151235A JPS5775991A (en) | 1980-10-27 | 1980-10-27 | Novel physiologically active substance jcv-80 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5775991A true JPS5775991A (en) | 1982-05-12 |
JPS6325599B2 JPS6325599B2 (en) | 1988-05-26 |
Family
ID=15514197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP55151235A Granted JPS5775991A (en) | 1980-10-27 | 1980-10-27 | Novel physiologically active substance jcv-80 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5775991A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5835117A (en) * | 1981-08-25 | 1983-03-01 | Nippon Zoki Pharmaceut Co Ltd | Novel physiologically active substance, nsh |
JPS59118711A (en) * | 1982-12-25 | 1984-07-09 | Nippon Zoki Pharmaceut Co Ltd | Novel physiologically active substance |
JPS6429389A (en) * | 1987-07-23 | 1989-01-31 | Nippon Zoki Pharmaceutical Co | Novel physiologically active substance and production thereof |
JPH0228115A (en) * | 1988-04-30 | 1990-01-30 | Nippon Zoki Pharmaceut Co Ltd | Physiologically active substance and pharmaceutical composition containing the same substance |
-
1980
- 1980-10-27 JP JP55151235A patent/JPS5775991A/en active Granted
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5835117A (en) * | 1981-08-25 | 1983-03-01 | Nippon Zoki Pharmaceut Co Ltd | Novel physiologically active substance, nsh |
JPH0343279B2 (en) * | 1981-08-25 | 1991-07-01 | Nippon Zoki Pharmaceutical Co | |
JPS59118711A (en) * | 1982-12-25 | 1984-07-09 | Nippon Zoki Pharmaceut Co Ltd | Novel physiologically active substance |
JPH0330598B2 (en) * | 1982-12-25 | 1991-04-30 | ||
JPS6429389A (en) * | 1987-07-23 | 1989-01-31 | Nippon Zoki Pharmaceutical Co | Novel physiologically active substance and production thereof |
JPH0228115A (en) * | 1988-04-30 | 1990-01-30 | Nippon Zoki Pharmaceut Co Ltd | Physiologically active substance and pharmaceutical composition containing the same substance |
Also Published As
Publication number | Publication date |
---|---|
JPS6325599B2 (en) | 1988-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
D Ley et al. | Ultraviolet radiation‐induced malignant melanoma in Monodelphis domestica | |
Mathews | Protective effect of β-carotene against lethal photosensitization by haematoporphyrin | |
IT1163737B (en) | BIPOLAR ELECTROLIZER INCLUDING MEANS TO GENERATE THE INTERNAL RECIRCULATION OF THE ELECTROLYTE AND ELECTROLYSIS PROCEDURE | |
IT1129682B (en) | BIOCONVERSION OF AGRICULTURAL WASTE INTO PROTEIN FOOD FOR ANIMAL FEEDING | |
DE69633236D1 (en) | TISSUE OR CELL SPECIFIC HERPESSIMPLEX VIRUS REPLICATION | |
Ley et al. | Photoreactivation of ultraviolet radiation-induced skin and eye tumors of Monodelphis domestica | |
ES8503941A1 (en) | Cosmetic preparations for promoting trophism of the skin and of related hair follicles | |
ATE33556T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING ADENOSIN DERIVATIVES FOR TREATMENT OF TUMORS. | |
ES478967A1 (en) | 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds | |
JPS5743695A (en) | Preparation of human follicle-stimulating hormone | |
JPS5587724A (en) | Selective immune enhancer | |
JPS5775991A (en) | Novel physiologically active substance jcv-80 | |
JPS5743696A (en) | Preparation of human luteinizing hormone | |
ES413316A1 (en) | Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases | |
CA2098113A1 (en) | Substances of polypeptide nature useful in human therapy | |
GB1317710A (en) | Poultry vaccine | |
LU78951A1 (en) | NEW VACCINE | |
ATE74761T1 (en) | USE OF PLANT POLLEN EXTRACTS FOR THE MANUFACTURE OF TUMOR CELL GROWTH INHIBITING PHARMACEUTICAL PREPARATIONS AND PROCESS FOR THEIR MANUFACTURE. | |
Ward | Gammarus pulex control their moult timing to secure mates. | |
Montgomery et al. | A vesiculo-bullous disease in pigs resembling foot and mouth disease II. Experimental reproduction of the lesion | |
Eisenbarth et al. | Inhibition of chondromucoprotein synthesis: an extraneuronal effect of nerve growth factor. | |
KAGAWA et al. | Histochemical demonstration of hydrolytic enzymes and dehydrogenases in the oral mucosa of cats | |
Gillard et al. | Germination of Phaseolus vulgaris: IV. Patterns of Protein Synthesis in Excised Axes | |
Osborn | Studies on the Growth of Integumentary Pigment in the Lower Vertebrates: II. The Rôle of the Hypophysis in Melanogenesis in the Common Catfish (Ameiurus melas) | |
GB1133958A (en) | Process for the manufacture of a distemper vaccine |